HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

aspartoacylase

deficiency results in CANAVAN DISEASE; RefSeq NM_000049 (human)
Also Known As:
ASPA protein, human; N-acyl-L-aspartate amidohydrolase; aminoacylase II
Networked: 134 relevant articles (1 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Matalon, Reuben: 13 articles (12/2020 - 05/2003)
2. Moffett, John R: 8 articles (01/2022 - 10/2005)
3. Surendran, Sankar: 8 articles (12/2010 - 05/2003)
4. Viola, Ronald E: 7 articles (01/2020 - 05/2006)
5. Leone, Paola: 6 articles (12/2016 - 07/2002)
6. Serikawa, Tadao: 6 articles (01/2009 - 08/2002)
7. Tyring, Stephen K: 6 articles (07/2006 - 05/2003)
8. Burns, Travis: 5 articles (11/2021 - 05/2015)
9. Guo, Fuzheng: 5 articles (11/2021 - 05/2015)
10. Pleasure, David: 5 articles (11/2021 - 05/2015)

Related Diseases

1. Canavan Disease (Leukodystrophy, Spongiform)
2. Nervous System Diseases (Neurological Disorders)
3. Tremor (Tremors)
4. Seizures (Absence Seizure)
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Lipids
2. Enzymes
3. N-acetylaspartate (N-acetyl aspartate)
4. Acetates (Acetic Acid Esters)
5. Biomarkers (Surrogate Marker)
6. Acetyltransferases
7. Aspartic Acid (Aspartate)
8. Proteins (Proteins, Gene)
9. Peptides (Polypeptides)
10. aspartoacylase

Related Therapies and Procedures

1. Therapeutics
2. Enzyme Replacement Therapy